1-228174995-C-T

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS1

The NM_001010867.4(IBA57):​c.645C>T​(p.Asp215Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000183 in 1,549,230 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0010 ( 1 hom., cov: 33)
Exomes 𝑓: 0.000089 ( 0 hom. )

Consequence

IBA57
NM_001010867.4 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.0850

Publications

0 publications found
Variant links:
Genes affected
IBA57 (HGNC:27302): (iron-sulfur cluster assembly factor IBA57) The protein encoded by this gene localizes to the mitochondrion and is part of the iron-sulfur cluster assembly pathway. The encoded protein functions late in the biosynthesis of mitochondrial 4Fe-4S proteins. Defects in this gene have been associated with autosomal recessive spastic paraplegia-74 and with multiple mitochondrial dysfunctions syndrome-3. Two transcript variants encoding different isoforms have been found for this gene. The smaller isoform is not likely to be localized to the mitochondrion since it lacks the amino-terminal transit peptide. [provided by RefSeq, Jul 2015]
IBA57 Gene-Disease associations (from GenCC):
  • mitochondrial disease
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • multiple mitochondrial dysfunctions syndrome 3
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet
  • hereditary spastic paraplegia 74
    Inheritance: AR Classification: SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 1-228174995-C-T is Benign according to our data. Variant chr1-228174995-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 541313.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.085 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00104 (158/152028) while in subpopulation AFR AF = 0.00372 (154/41444). AF 95% confidence interval is 0.00324. There are 1 homozygotes in GnomAd4. There are 69 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IBA57NM_001010867.4 linkc.645C>T p.Asp215Asp synonymous_variant Exon 2 of 3 ENST00000366711.4 NP_001010867.1 Q5T440
IBA57NM_001310327.2 linkc.66C>T p.Asp22Asp synonymous_variant Exon 2 of 3 NP_001297256.1 B4E1G9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IBA57ENST00000366711.4 linkc.645C>T p.Asp215Asp synonymous_variant Exon 2 of 3 2 NM_001010867.4 ENSP00000355672.3 Q5T440
IBA57ENST00000484749.5 linkn.2645C>T non_coding_transcript_exon_variant Exon 2 of 3 5
IBA57ENST00000546123.2 linkn.365C>T non_coding_transcript_exon_variant Exon 2 of 3 2

Frequencies

GnomAD3 genomes
AF:
0.00102
AC:
155
AN:
151908
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00365
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000196
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000479
GnomAD2 exomes
AF:
0.000278
AC:
56
AN:
201282
AF XY:
0.000213
show subpopulations
Gnomad AFR exome
AF:
0.00330
Gnomad AMR exome
AF:
0.000171
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000110
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000895
AC:
125
AN:
1397202
Hom.:
0
Cov.:
32
AF XY:
0.0000859
AC XY:
59
AN XY:
686610
show subpopulations
African (AFR)
AF:
0.00334
AC:
107
AN:
32002
American (AMR)
AF:
0.0000772
AC:
3
AN:
38880
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
22002
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39006
South Asian (SAS)
AF:
0.00
AC:
0
AN:
76772
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
48718
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5446
European-Non Finnish (NFE)
AF:
0.0000102
AC:
11
AN:
1076908
Other (OTH)
AF:
0.0000696
AC:
4
AN:
57468
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
8
15
23
30
38
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00104
AC:
158
AN:
152028
Hom.:
1
Cov.:
33
AF XY:
0.000928
AC XY:
69
AN XY:
74324
show subpopulations
African (AFR)
AF:
0.00372
AC:
154
AN:
41444
American (AMR)
AF:
0.000196
AC:
3
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5148
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4816
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10600
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
67938
Other (OTH)
AF:
0.000474
AC:
1
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
10
21
31
42
52
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000537
Hom.:
0
Bravo
AF:
0.00121
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Multiple mitochondrial dysfunctions syndrome 3;C5568837:Hereditary spastic paraplegia 74 Benign:1
Oct 29, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

IBA57-related disorder Benign:1
Aug 13, 2019
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

not provided Benign:1
May 01, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
CADD
Benign
1.8
DANN
Benign
0.33
PhyloP100
-0.085
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61743941; hg19: chr1-228362696; API